Skip to content
10-Q

Quarterly Report

AMEXDRUG CORP

0001096906-11-002747

← back to feed
Filed
Nov 14, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 9, 2011 8.46M sh
Shares Diluted Q3 2011 · Sep 30, 2011 8.47M sh
Shares Diluted Q3 2011 · Sep 30, 2011 8.47M sh
Shares Diluted Q3 2011 · Sep 30, 2010 8.47M sh
Shares Diluted Q3 2011 · Sep 30, 2010 8.47M sh
Cash And Equivalents Q3 2011 · Sep 30, 2011 $141.54K
Cash And Equivalents Q3 2011 · Dec 31, 2010 $443.7K
Cash And Equivalents Q3 2011 · Sep 30, 2010 $303.36K
Cash And Equivalents Q3 2011 · Dec 31, 2009 $121.18K
Stockholders Equity Q3 2011 · Sep 30, 2011 $567.59K
Stockholders Equity Q3 2011 · Dec 31, 2010 $250.51K
Current Liabilities Q3 2011 · Sep 30, 2011 $849.33K
Current Liabilities Q3 2011 · Dec 31, 2010 $1.09M
Current Assets Q3 2011 · Sep 30, 2011 $1.33M
Current Assets Q3 2011 · Dec 31, 2010 $1.29M
Total Assets Q3 2011 · Sep 30, 2011 $1.42M
Total Assets Q3 2011 · Dec 31, 2010 $1.34M
Stock Repurchased Q3 2011 · Sep 30, 2010 $1.55K
Capex Q3 2011 · Sep 30, 2010 $4.04K
Operating Cash Flow Q3 2011 · Sep 30, 2010 $177.14K
Sga Expense Q3 2011 · Sep 30, 2010 $153.92K
Sga Expense Q3 2011 · Sep 30, 2010 $426.42K
Net Income Q3 2011 · Sep 30, 2010 $54.52K
Net Income Q3 2011 · Sep 30, 2010 $203.06K
Operating Income Q3 2011 · Sep 30, 2010 $101.14K
Operating Income Q3 2011 · Sep 30, 2010 $328.68K
Gross Profit Q3 2011 · Sep 30, 2010 $256.82K
Gross Profit Q3 2011 · Sep 30, 2010 $762.08K
Cost Of Revenue Q3 2011 · Sep 30, 2010 $2.68M
Cost Of Revenue Q3 2011 · Sep 30, 2010 $7.86M
Revenue Q3 2011 · Sep 30, 2010 $2.93M
Revenue Q3 2011 · Sep 30, 2010 $8.62M